GM

George M. Church

Founder of Eugit Therapeutics

Boston, Massachusetts

Overview 

George M. Church is a Professor at Harvard Medical School and MIT, with significant achievements in co-founding multiple successful biotech companies like Editas Medicine and eGenesis, and serving as an advisor to Genome Compiler Corp. and Gen9, Inc. He has made impactful investments in companies such as Orchid and Axcella, showcasing his expertise in biotechnology entrepreneurship and technology transfer.

Work Experience 

  • Professor

    1986 - Current

    Research & Teaching

  • Co-Founder

    2022

Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.

Raised $500,000.00 from Y Combinator.

  • Co-Founder

    2021

    Arctic elephants & veterinary reproductive technologies.

Colossal Biosciences is a biotechnology research & reproductive technology.

  • Co-Founder

    2018

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

Raised $109,000,000.00 from Polaris Partners, KdT Ventures, Sahsen Ventures, Obvious Ventures, Andreessen Horowitz, CRV, Lux Capital, Casdin Capital and Google Ventures.

  • Co-Founder

    2019

SaaS App for content creators to turbo charge the performance of their viral idea

Raised $1,000,000.00.

  • Co-Founder

    2015

  • Co-Founder

    2013

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Raised $931,600,000.00 from Khosla Ventures, Omega Funds, Boris Nikolic, Third Rock Ventures, Jennison Associates, Innova Capital, Polaris Partners, Google Ventures, EcoR1 Capital and Fidelity.

  • Advisor

    2011

    Nanopore DNA sequencing

  • Founder

    2009

Articles About George

Relevant Websites